Kenvue Inc. Common Stock vs Under Armour Inc Class A — how do they compare? Kenvue Inc. Common Stock trades at $17.71 (market cap $34.06B), while Under Armour Inc Class A trades at $4.82 (market cap $2.07B). The key difference: Kenvue Inc. Common Stock is far larger — about 16.5× Under Armour Inc Class A's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while Under Armour Inc Class A pays none. Which is the better fit depends on your goals.
| KVUE | UA | |
|---|---|---|
Market Cap | $34.06B | $2.07B |
Volume | 23,267,228 | 2,680,141 |
Sector | Consumer Staples | Consumer Cyclical |
52-Week High | $19.83 | $7.88 |
52-Week Low | $14.11 | $3.96 |
Enterprise Value | $41.56B | $3.05B |
Dividend Yield | 4.74% | — |
Typical Hold Time | — | 18 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Under Armour (UA) trades at $4.81, up 2.34% with a bullish technical signal despite mixed fundamentals. The company reported declining revenues ($5.16B in 2025, $4.9B in 2026) and negative net income margins (-9.99%), though recent quarterly earnings showed beats in Q4 2025 and Q2 2026. Analyst sentiment is divided with 39.71% buy ratings, while cash flow trends show significant outflows (-$362M net in 2025).
The outlook remains challenging with revenue declines and profitability concerns, but the stock's low P/S ratio (0.41) may attract value investors. Key risks include sustained negative cash flow, competitive pressures, and execution on turnaround strategies. Near-term performance hinges on Q3 2026 earnings and guidance updates.
Trailing returns across standard periods
Latest headlines on both assets
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →Under Armour is a leading inventor, marketer, and distributor of branded athletic performance apparel, footwear, and accessories. Built on the 'technical' performance of synthetic fabrics, the company is currently undergoing a multi-year brand evolution centered on premium product innovation, operational rigor, and a renewed focus on its North American core under the guidance of founder Kevin Plank.
Read more on UA →